ListarArtículos (Medicina) por materia "Palbociclib"
Mostrando ítems 1-2 de 2
-
Artículo
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial
(Sage Journals, 2023)Background: In the FLIPPER trial, palbociclib/fulvestrant significantly improved progression free survival (PFS) compared ...
-
Artículo
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)
(ELSEVIER SCI LTD, 2022)Background The potential benefit of adding palbociclib to fulvestrant as first-line treatment in hormone receptor ...